April 30, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 16,573 shares of Abrdn Life Sciences Investors at $13.13 per share, a transaction worth $217.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.